Current research into drug treatments for CLL - specifically ibrutinib, idelalisib and venetoclax
CLL updates from ASH 2017
2 years on: Deborah discusses her venetoclax trial and becoming MRD negative
Deborah Henderson et al.
Results of the Phase III DASISION trial and the future of CML treatment
Advances in multiple myeloma treatment over the last years